Welcome to our dedicated page for Cooper news (Ticker: COO), a resource for investors and traders seeking the latest updates and insights on Cooper stock.
CooperCompanies (NYSE: COO) delivers essential updates from the forefront of medical device innovation through its CooperVision and CooperSurgical divisions. This hub provides investors and healthcare professionals with direct access to official announcements, including product developments, regulatory milestones, and strategic initiatives shaping the vision care and women's health sectors.
Find curated press releases covering earnings results, clinical trial updates, and market expansion activities. Track innovations in silicone hydrogel contact lenses and fertility treatment technologies alongside analysis of industry trends impacting COO's global operations. Our repository simplifies monitoring of key developments across 130+ countries where Cooper's life-enhancing devices serve patients and providers.
Bookmark this page for real-time updates on FDA clearances, acquisition activity, and leadership changes. Subscribe to alerts for breaking news about COO's specialty lens portfolio and reproductive health solutions maintaining its position as a medical technology leader.
CooperCompanies (Nasdaq: COO) announced its Q2 2024 financial results, showing a 7% year-over-year revenue increase to $942.6 million. CooperVision (CVI) revenue rose 8% to $635.9 million, while CooperSurgical (CSI) revenue increased 6% to $306.7 million. GAAP diluted EPS was $0.44, up 122% from last year's Q2. Non-GAAP diluted EPS was $0.85, a 10% increase. Gross margin held steady at 67%. Operating margin improved to 17% from 11% last year. Interest expense rose to $28.9 million due to higher debt and interest rates. Free cash flow was $36.9 million. The company raised its FY 2024 guidance, predicting total revenue of $3.863-$3.905 billion and non-GAAP EPS of $3.54-$3.60.
CooperCompanies released its 2023 Environmental, Social, and Governance (ESG) Report, highlighting their efforts in health, wellness, and environmental protection. The company made healthcare solutions more accessible in underserved communities and invested in global employee development. The report, aligned with the Sustainability Accounting Standards Board (SASB) framework, provides updated and expanded ESG performance data. CEO Al White emphasized the company's commitment to sustainability and innovation.
Find the full report at: https://coopercos.com/esg/
CooperCompanies (Nasdaq: COO), a global leader in medical devices, announced its participation in the Jefferies Global Healthcare Conference on June 6, 2024. Brian Andrews, the Executive Vice President, Chief Financial Officer & Treasurer, will represent the company in a session at 1:30 PM ET. The presentation will be accessible via a webcast on the CooperCompanies' investor relations website.
CooperCompanies (Nasdaq: COO), a global medical device firm, is set to participate in the William Blair Growth Stock Conference on June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the company in a session at 11:00 AM ET. Interested parties can view the webcast via the CooperCompanies' investor website.
The Canadian Association of Optometrists has launched a digital campaign called 'GetEyeWise' during Vision Health Month to raise awareness about eye health and encourage regular eye exams. The campaign aims to educate Canadians about the importance of eye care, especially early detection of eye-threatening conditions. With the support of various provincial associations of optometrists and industry sponsors, the initiative highlights the urgent need for public education on eye health and vision care.
CooperCompanies will release its second quarter 2024 financial results on May 30, 2024, at 4:15 PM ET. A conference call to discuss the results and corporate developments will follow at 5:00 PM ET. Investors can access the call via dial-in number 800-715-9871 and conference ID 1712676. An audio webcast and replay will be available at http://investor.coopercos.com.
FAQ
What is the current stock price of Cooper (COO)?
What is the market cap of Cooper (COO)?
